On October 30, 2006, Savient Pharmaceuticals, Inc. (the “Registrant”) announced its financial results for the quarter and nine months ended September 30, 2006. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
In addition, on October 31, 2006, the Registrant held a publicly available live webcast discussion of its financial results for the quarter ended September 30, 2006. The transcript of the October 31, 2006 conference call is furnished as Exhibit 99.2 to this Current Report on Form 8-K.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
See Exhibit Index attached hereto.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| SAVIENT PHARMACEUTICALS, INC. | |
| Date: November 2, 2006 | By: /s/ Philip K. Yachmetz |
| Philip K. Yachmetz Executive Vice President & Chief Business Officer |
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | Press release dated October 30, 2006 | |
| 99.2 | Transcript dated October 31, 2006 |
